Skip to content
  • About Sakar
    • Key Milestones / History
    • Mission, Vision & Values
    • Management Desk
    • Rewards & Recognitions
  • Business
    • Facility
    • Exports
    • Research & Development
    • Quality
    • Future Plans
    • Corporate Social Responsibility
  • General Product
    • Oral – Liquid Syrup & Suspension
    • Liquid Injectable (Svp) – Vials & Ampoules
    • Cephalosporin – Dry Powder Injections
    • Cephalosporin – Oral Solid
    • Lyophilised Injections (In Vials)
  • Oncology Product
    • Oral (Tablet, Capsule, Granules & Liquid)
    • Liquid Injection
    • Lyophilised Injection
    • Active Pharmaceutical Ingredient(Api)
    • CDMO Products
    • CRAMs
  • Clients
  • Investor Relations
    • Financial Reports (Quarterly & Annually)
      • Quarterly
        • Financial Results
        • Investor Presentation
        • Earning Audio Call Recording
        • Earning Call Transcript
        • Shareholding Pattern
        • Press Release
        • Earnings call Invite
        • Factsheet (Quarterly/Annually)
      • Annual
        • Annual Report
      • Subsidiary financials
        • Quarterty
        • Annually
    • Board of Directors
      • Board of Directors
      • Committees
    • Shareholder’s Information
      • Share Price Information From BSE & NSE
      • Notices and Intimations
      • Corporate Announcement
      • Shareholder’s Meet / AGM
      • Credit Rating
      • Policies
    • Corporate Governance
      • Corporate Governance Report
      • Appointment of Committee Members, Key Managerial Positions
      • Documents related to Corporate governance, Compliance
    • Board of Directors
      • Board Of Directors
      • Event Calendar
    • Investor Support
      • Registrar, Company Secretary and Transfer Agent Information
      • Grievance Redressal
      • Reverse Enquiry Toolkit
  • News & Award
    • Rewards & Recognitions
  • Careers
  • Contact Us
  • About Sakar
    • Key Milestones / History
    • Mission, Vision & Values
    • Management Desk
    • Rewards & Recognitions
  • Business
    • Facility
    • Exports
    • Research & Development
    • Quality
    • Future Plans
    • Corporate Social Responsibility
  • General Product
    • Oral – Liquid Syrup & Suspension
    • Liquid Injectable (Svp) – Vials & Ampoules
    • Cephalosporin – Dry Powder Injections
    • Cephalosporin – Oral Solid
    • Lyophilised Injections (In Vials)
  • Oncology Product
    • Oral (Tablet, Capsule, Granules & Liquid)
    • Liquid Injection
    • Lyophilised Injection
    • Active Pharmaceutical Ingredient(Api)
    • CDMO Products
    • CRAMs
  • Clients
  • Investor Relations
    • Financial Reports (Quarterly & Annually)
      • Quarterly
        • Financial Results
        • Investor Presentation
        • Earning Audio Call Recording
        • Earning Call Transcript
        • Shareholding Pattern
        • Press Release
        • Earnings call Invite
        • Factsheet (Quarterly/Annually)
      • Annual
        • Annual Report
      • Subsidiary financials
        • Quarterty
        • Annually
    • Board of Directors
      • Board of Directors
      • Committees
    • Shareholder’s Information
      • Share Price Information From BSE & NSE
      • Notices and Intimations
      • Corporate Announcement
      • Shareholder’s Meet / AGM
      • Credit Rating
      • Policies
    • Corporate Governance
      • Corporate Governance Report
      • Appointment of Committee Members, Key Managerial Positions
      • Documents related to Corporate governance, Compliance
    • Board of Directors
      • Board Of Directors
      • Event Calendar
    • Investor Support
      • Registrar, Company Secretary and Transfer Agent Information
      • Grievance Redressal
      • Reverse Enquiry Toolkit
  • News & Award
    • Rewards & Recognitions
  • Careers
  • Contact Us

Category: Corporate Announcement

Sakar_Interaction_with_Investor_14th November 2022

Statement of Deviation or Variation under regulation 32 of SEBI(LODR) Regulations, 2015 for the quarter ended on September 30, 2021

Intimation Letter under regulation 30 of SEBI (LODR) Regulations, 2015 for submission of advertisement publication

Updates_on_API_progressed_ in_oncology_segment

Re-appointment of directors in 17th AGM

Sakar Healthcare Investor Presentation

Sakar_Interaction_with_Investor_2nd November 2022

SAKAR Healthcare – Inauguration of Research Laboratories (R&D, F&D, ADL)

Intimation Letter under regulation 30 of SEBI (LODR) Regulations, 2015 , dated 29th November 2018

Sakar_Interaction_with_Investor_12th October 2022

← Previous
Next →

Sakar Healthcare Ltd delivers quality
healthcare solutions worldwide.

Office

  • 406, Silver Oaks Comm. Complex,
    Opp. Arun Society, Paldi, Ahmedabad
    380007 Gujarat – India.
  • info@sakarhealthcare.com
  • 079 – 26588054

Links

  • Key Milestones / History
  • Vision & mission
  • Careers
  • Gallery
  • Exports
  • Contact Us

Products

  • Oral - Liquid Syrup & Suspension
  • Liquid Injectable (Svp) - Vials & Ampoules
  • Oral (Tablet, Capsule, Granules & Liquid)
  • Liquid Injection
Copyright © 2026 Sakar Healthcare Ltd. All Rights Reserved
Powered By : Adit Microsys

Office

  • 406, Silver Oaks Comm. Complex,
    Opp. Arun Society, Paldi, Ahmedabad
    380007 Gujarat – India.
  • info@sakarhealthcare.com
  • 079 – 26588054

Links

  • Home
  • Key Milestones / History
  • Careers
  • Gallery
  • Contact Us

Profile

  • Vision & mission
  • Future Plans
  • Exports
  • Corporate Social Responsibility

Products

  • Oral - Liquid Syrup & Suspension
  • Liquid Injectable (Svp) - Vials & Ampoules
  • Oral (Tablet, Capsule, Granules & Liquid)
  • Liquid Injection
Copyright © 2026 Sakar Healthcare Ltd. All Rights Reserved

Powered By : Adit Microsys

  • Home
  • Prestigious Clients
  • Careers
  • Gallery
  • Enquiry
  • Contact Us

Profile

  • About Us
  • Vision & Mission
  • Exports
  • Future Plans
  • Corporate Social Responsibility

Strength

  • Quality
  • Research & Development
  • Facility

Products

  • Oral - Liquid Syrup & Suspension
  • Liquid Injectable (Svp) - Vials & Ampoules
  • Cephalosporin - Dry Powder Injections
  • Cephalosporin – Oral Solid
  • Lyophilised Injections (In Vials) - EU GMP Approved

Copyright © 2026 Sakar Healthcare Ltd. All Rights Reserved

Powered By : Adit Microsys